Brief: Kala Pharmaceuticals Q2 EPS USD -4.36

KALA BIO

04/08/2023 13:00

Aug 04 (Reuters) - Kala Pharmaceuticals Q2 income from operations USD -9.599
million.
* Q2 operating expenses USD 9.599 million
* Q2 net income USD -10.413 million